Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 198

PDF Downloaded: 36


Get Permission Beniwal, Thiruvengadam, Saharan, Parvez, Malik, and Muruganandam: Burden of ocular infections in the Andaman Islands, India: An overview of clinical and epidemiological factors from 2017-2021


Introduction

Ocular infections are a significant public health concern with implications for both individual well-being and broader healthcare systems. The delicate nature of the eye and its susceptibility to various pathogens and environmental factors make ocular infections a complex and diverse field of study. These infections can range from mild cases of conjunctivitis to severe corneal ulcers, potentially leading to vision impairment or even blindness. The Andaman Islands, located in the Bay of Bengal, represent a unique setting to study ocular infections due to their distinct geographical and climatic characteristics. With a population of nearly 380,000 people residing on around 500 islands, this region provides an opportunity to explore the interplay between environmental factors, individual susceptibility, and infectious agents in the context of ocular health. The emergence of the COVID-19 pandemic further complicates the landscape of ocular infections. The SARS-CoV-2 virus, responsible for COVID-19, has been associated with ocular symptoms such as conjunctivitis and eye irritation. Understanding the prevalence and impact of COVID-19-related ocular issues within the specific context of the Andaman Islands is of paramount importance for both immediate patient care and long-term public health planning.

Diagnosing ocular infections in the laboratory is challenging due to the complexity of the eye. Conditions like uveitis, iritis, and chorioretinal cellulitis are considered sterile, while conjunctivitis, dacryocystitis, blepharitis, canaliculitis, preseptal, and septal cellulitis are non-sterile.1 Eye infections are categorized into outer eye infections affecting susceptible structures and inner eye infections affecting protected structures. Outer eye infections can be easily sampled through swabs for detection, whereas inner eye infections cannot be reached by swabs. These infections can be induced by environmental factors or the patient's microbiome. Both endogenous (systemic) and exogenous (environmental or microbiome-related) factors can cause inner eye infections.2

The thin, transparent conjunctiva covering the sclera and inner eyelids remains largely unchanged.1 Inflammation in the eye can lead to conjunctivitis, which can either develop as a primary symptom or secondary to other conditions.3 Conjunctivitis has infectious and non-infectious causes, with viruses and bacteria being the primary culprits for infectious cases. Non-infectious conjunctivitis includes various types like allergic, toxic, cicatricial, immune-mediated, and neoplastic-related.4 The severity and speed of spread determine whether the condition is acute, hyper-acute, or chronic.

Infectious conjunctivitis is highly contagious and a public health concern. Key clinical indicators include "red eye" (conjunctival hyperemia) affecting the bulbar and/or palpebral/tarsal conjunctiva, often accompanied by discomfort and discharge.3, 4 Given the recognizable clinical signs, extensive testing is usually unnecessary.3 Most cases are viral, caused by Adenovirus, Herpes simplex virus, and enterovirus, resulting in bilateral watery eye inflammation linked to contact with infected individuals.4, 5, 6, 7 Symptoms can include redness, itching, discharge, conjunctival injection, pre-auricular lymphadenopathy, and follicular inflammation.8, 9 Bacterial conjunctivitis, primarily caused by organisms like Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae, tends to affect a single eye and displays purulent discharge and matting.3, 4 Neisseria gonorrhoeae-induced conjunctivitis is particularly dangerous, especially in infants and sexually active adults.10, 11, 12 Chlamydia trachomatis-related keratoconjunctivitis leads to trachoma, a sight-threatening infection causing corneal scarring and blindness. The SAFE global initiative aims to combat trachoma through interventions like surgery, antimicrobials, hygiene practices, and environmental improvements.13

In the Andaman and Nicobar Islands, a group of islands in the Bay of Bengal, this study presents the clinical-epidemiological pattern of keratoconjunctivitis. By analysing data from a referral hospital in South Andaman, the study contributes to understanding this ocular infection and improving prevention and control strategies. The analysis involves assessing diverse disease presentations to gauge changes in the clinical spectrum and enhance diagnostic accuracy. In this study, we aim to provide a comprehensive analysis of the epidemiological patterns, clinical manifestations, and potential risk factors associated with ocular infections on the Andaman Islands. By examining both infectious and non-infectious causes, we seek to elucidate the factors driving the occurrence of ocular infections and their implications for the local population. Furthermore, we will explore the impact of the COVID-19 pandemic on the landscape of ocular infections, shedding light on potential shifts in patterns and priorities. Through a thorough investigation of the prevalence and characteristics of ocular infections, we aim to contribute valuable insights to the field of ocular health, inform healthcare policies, and guide future research efforts. This study not only addresses immediate health concerns but also lays the groundwork for proactive measures to mitigate the impact of ocular infections and ensure optimal eye health in the Andaman Islands and beyond.

Materials and Methods

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Human Ethical Committee of ICMR- Regional Medical Research Centre, Port Blair, Andaman and Nicobar Islands, India for the project entitled “A multi-centric hospital-based study on epidemiology of Keratoconjunctivitis in India”. (RMRC/IEC/2017/06).

The Andaman and Nicobar Islands consist of more than 500 islands, situated in the Bay of Bengal between 92° and 94° East longitude and 6° and 14° North latitude. Among these islands, 38 are inhabited, with a total population of 379,944 individuals.14 This study focuses on the population of the Andaman Islands.

This study involves a hospital-based observational analysis of individuals with clinically suspected ocular complications who sought care at the Agarwal Eye Care Centre in the Andaman Islands.

The primary criteria to suspect conjunctivitis encompassed patients visiting the ophthalmologist due to the presence of redness, watering, or discharge in one or both eyes.

Informed consent statement

Informed consent was obtained from all subjects involved in the study.

Data collection

The data from hospital were gathered like general information from the subjects, encompassing aspects such as residence, onset season, clinical presentations, gender (male or female), age (across all age groups), symptom onset, recent travel history (within the last 14 days), and any existing co-morbidities (e.g., Diabetes Mellitus, Hypertension, Thyroid conditions).

Observational metrics

The epidemiological characteristics of acute infectious conjunctivitis (AIC), including symptom onset, age distribution, seasonal trends, and clinical manifestations, were subjected to analysis. The collected general data were examined to identify potential risk factors influencing the occurrence of acute infectious conjunctivitis.

Before analysis, data were meticulously examined for potential duplicates, outliers, and logical consistency. The statistical computations were conducted using STATA v15.1 (Stata Corporation, College Station, TX, USA). Descriptive analysis was used to summarize patient characteristics, presenting outcomes as frequencies and percentages. The association between factors and the presence of viral and/or bacterial infections before and after COVID-19 was explored using the Fishers exact and Chi-square test. To assess the trend of viral and bacterial infection over time, the Dickey-Fuller unit root test was used to verify time independence. Additionally, the influence of COVID-19 interruptions on infection diagnosis was assessed using interrupted time series analysis. All statistical tests were two-tailed, with a significance level set at alpha = 0.05.

Results

Comprehensiveexamination of general epidemiological characteristics: Over the duration spanning August 2017 to August 2021, a total of 10,533 instances of acute infectious conjunctivitis (AIC) were reported. Among these, 10,519 patients were investigated for kerato-conjunctivitis, revealing that 49.4% (5,200 individuals) exhibited no specific keratoconjunctivitis-related symptoms. Of the remaining cases, 50.6% showed signs of potential ocular infections. Further scrutiny indicated that the primary causative agent was non-infectious in nature, accounting for the majority (78.8%) of cases. Out of 1,129 cases suspected of having infectious ocular infections, 84.2% were attributed to viral origin, 32.6% to bacterial origin, and 18% displayed an association with both viral and bacterial etiologies (Figure 1).

Chart 1

The flowchart showing the classification of the study participants

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/91b74b45-7dc9-4cb6-b072-6d31bcd81c31/image/e480c164-bc16-4477-b135-a763d99a12a9-uimage.png

Commonalities and disparities in suspected cases: Among the total 5,319 suspected cases, the age group of 31-40 exhibited a disproportionate share (20.10%) during the study period. Gender distribution showed no significant difference, with females comprising a slightly higher percentage (50.3%). While there was no statistically significant dissimilarity between left and right eye presentations, unilateral cases were more prevalent. Predominant clinical features associated with suspected cases included redness (47.5%), eye-watering (41.2%), and itching (26.5%). Pain was reported by 32.9% of patients, while blurred vision was experienced by 10% of all suspected cases. Additionally, 1,321 out of 5,319 patients had a history of wearing glasses, 520 (9.8%) had hypertension, 9.3% had diabetes mellitus, and only 2.4% suspected ocular infections displayed cataracts. Nearly half of the total cases sought consultation from an optometrist within a week of symptom onset (Table 1).

Table 1

Association of demographic and clinical factors with the pre and post-COVID observations

Pre-Covid [n=4401]

Post-Covid [n=918]

Total [n=5319]

n

%

N

%

n

%

Age (in Years)

≤10

657

14.9

89

9.7

746

14.0

11-20

552

12.5

75

8.2

627

11.8

21-30

874

19.9

180

19.6

1,054

19.8

31-40

872

19.8

197

21.5

1,069

20.1

41-50

644

14.6

159

17.3

803

15.1

51-60

466

10.6

119

13.0

585

11.0

61-70

238

5.4

75

8.2

313

5.9

>70

98

2.2

24

2.6

122

2.3

P-value<0.001

Gender of the Participant

Male

2,171

49.3

472

51.4

2,643

49.7

Female

2,230

50.7

446

48.6

2,676

50.3

P-value=0.250

Visited Year

2017

588

13.4

0

0.0

588

11.1

2018

1,961

44.6

0

0.0

1,961

36.9

2019

1,590

36.1

0

0.0

1,590

29.9

2020

262

6.0

419

45.6

681

12.8

2021

0

0.0

499

54.4

499

9.4

P-value<0.001

Eye Involvement

Not Assigned

397

9.0

59

6.4

456

8.6

Left Eye

1,211

27.5

273

29.7

1,484

27.9

Right Eye

1,169

26.6

266

29.0

1,435

27.0

Both Eye

1,624

36.9

320

34.9

1,944

36.5

P-value = 0.020

Pain

No

3,008

68.3

559

60.9

3,567

67.1

Yes

1,393

31.7

359

39.1

1,752

32.9

P-value<0.001

Redness

No

2,325

52.8

465

50.7

2,790

52.5

Yes

2,076

47.2

453

49.3

2,529

47.5

P-value = 0.230

Discharge

No

3,886

88.3

795

86.6

4,681

88.0

Yes

515

11.7

123

13.4

638

12.0

P-value = 0.150

Watering

No

2,584

58.7

546

59.5

3,130

58.8

Yes

1,817

41.3

372

40.5

2,189

41.2

P-value=0.669

Headache

No

4,051

92.0

847

92.3

4,898

92.1

Yes

350

8.0

71

7.7

421

7.9

P-value = 0.823

FB Sensation

No

4,071

92.5

842

91.7

4,913

92.4

Yes

330

7.5

76

8.3

406

7.6

P-value = 0.418

Itching

No

3,323

75.5

589

64.2

3,912

73.5

Yes

1,078

24.5

329

35.8

1,407

26.5

P-value<0.001

Irritation

No

3,786

86.0

846

92.2

4,632

87.1

Yes

615

14.0

72

7.8

687

12.9

P-value<0.001

Blurry Vision

No

3,983

90.5

803

87.5

4,786

90.0

Yes

418

9.5

115

12.5

533

10.0

P-value = 0.005

Onset of Symptoms

Not Assigned

555

12.6

157

17.1

712

13.4

≤1 Week

2,260

51.4

463

50.4

2,723

51.2

2 Week

330

7.5

79

8.6

409

7.7

3 Week

149

3.4

30

3.3

179

3.4

4 Week

4

0.1

1

0.1

5

0.1

5-6 Week

328

7.5

38

4.1

366

6.9

7-8 Week

177

4.0

36

3.9

213

4.0

>8 Week

598

13.6

114

12.4

712

13.4

P-value = 0.001

Hypertension

No

3,967

90.1

832

90.6

4,799

90.2

Yes

434

9.9

86

9.4

520

9.8

P-value = 0.647

Diabetes Mellitus

No

3,998

90.8

826

90.0

4,824

90.7

Yes

403

9.2

92

10.0

495

9.3

P-value = 0.412

Cataract

No

4,296

97.6

893

97.3

5,189

97.6

Yes

105

2.4

25

2.7

130

2.4

P-value = 0.547

Ocular Infection

No

3,480

79.1

710

77.3

4,190

78.8

Yes

921

20.9

208

22.7

1,129

21.2

P-value = 0.243

Viral Infection

No

3,627

82.4

742

80.8

4,369

82.1

Yes

774

17.6

176

19.2

950

17.9

P-value =0.254

Bacterial Infection

No

4,098

93.1

853

92.9

4,951

93.1

Yes

303

6.9

65

7.1

368

6.9

P-value=0.832

[i] % - Column Percentage; Source: Secondary Data Collection

Table 2

The factors associated with the viral and bacterial Infections

Total

Viral Infection

Bacterial Infection

N

%

n

%

n

%

Age (in Years)

≤10

166

14.7

116

12.2

80

21.7

11-20`

133

11.8

114

12.0

38

10.3

21-30

264

23.4

238

25.1

63

17.1

31-40

222

19.7

177

18.6

83

22.6

41-50

162

14.3

145

15.3

45

12.2

51-60

109

9.7

98

10.3

32

8.7

61-70

55

4.9

48

5.1

19

5.2

>70

18

1.6

14

1.5

8

2.2

p-Value

<0.001

<0.001

Gender of the Participant

Male

651

57.7

558

58.7

193

52.4

Female

478

42.3

392

41.3

175

47.6

p-Value

0.092

0.014

Visited Year

2017

112

9.9

86

9.1

43

11.7

2018

420

37.2

341

35.9

168

45.7

2019

334

29.6

301

31.7

74

20.1

2020

143

12.7

125

13.2

39

10.6

2021

120

10.6

97

10.2

44

12.0

p-Value

0.001

<0.001

Eye Involvement

Not Assigned

91

8.1

77

8.1

32

8.7

Left Eye

344

30.5

292

30.7

91

24.7

Right Eye

353

31.3

311

32.7

102

27.7

Both Eye

341

30.2

270

28.4

143

38.9

p-Value

0.014

<0.001

Pain

No

646

57.2

533

56.1

231

62.8

Yes

483

42.8

417

43.9

137

37.2

p-Value

0.081

0.009

Redness

Yes

1,129

100.0

950

100.0

368

100.0

p-Value

NA

NA

Discharge

No

761

67.4

761

80.1

0

0.0

Yes

368

32.6

189

19.9

368

100.0

p-Value

<0.001

<0.001

Watering

No

179

15.9

0

0.0

179

48.6

Yes

950

84.1

950

100.0

189

51.4

p-Value

<0.001

<0.001

Headache

No

1,099

97.3

926

97.5

359

97.6

Yes

30

2.7

24

2.5

9

2.4

p-Value

0.529

0.759

FB Sensation

No

1,060

93.9

886

93.3

352

95.7

Yes

69

6.1

64

6.7

16

4.3

p-Value

0.043

0.085

Itching

No

829

73.4

702

73.9

273

74.2

Yes

300

26.6

248

26.1

95

25.8

p-Value

0.413

0.689

Irritation

No

1,001

88.7

838

88.2

335

91.0

Yes

128

11.3

112

11.8

33

9.0

p-Value

0.27

0.081

Blurry Vision

No

1,069

94.7

896

94.3

354

96.2

Yes

60

5.3

54

5.7

14

3.8

p-Value

0.202

0.116

Onset of Symptoms

Not Assigned

89

7.9

77

8.1

23

6.3

≤1 Week

799

70.8

674

70.9

272

73.9

2 Week

92

8.1

76

8.0

35

9.5

3 Week

28

2.5

22

2.3

9

2.4

5-6 Week

42

3.7

36

3.8

11

3.0

7-8 Week

21

1.9

17

1.8

6

1.6

>8 Week

58

5.1

48

5.1

12

3.3

p-Value

0.957

0.201

Hypertension

No

1,050

93.0

884

93.1

343

93.2

Yes

79

7.0

66

6.9

25

6.8

p-Value

0.879

0.852

Diabetes Mellitus

No

1,040

92.1

874

92.0

336

91.3

Yes

89

7.9

76

8.0

32

8.7

p-Value

0.737

0.481

Cataract

No

1,107

98.1

929

97.8

362

98.4

Yes

22

1.9

21

2.2

6

1.6

p-Value

0.142

0.591

[i] % - Column Percentage; Source: Secondary Data Collection

Association of infectious factors during the COVID-19 period: Analysis unveiled notable shifts in clinical and demographic characteristics during the COVID-19 period. The age group most affected shifted to 31-40 (21.5%), as compared to the pre-pandemic distribution where 19.9% and 19.8% belonged to the 21-30 and 31-40 age groups, respectively. Furthermore, the male gender exhibited a higher impact during the COVID-19 period, whereas females were predominantly affected before the pandemic. Unilaterality remained a prevailing trend in both periods. Redness saw an increase during coronavirus pandemic (49.3%) compared to the pre-COVID period (47.2%). Eye-watering showed a decrease of 1% during the pandemic (41.3% pre-COVID). Remarkably, itching experienced a significant surge of approximately 11% during the COVID-19 period. Blurred vision, reported in 9.5% of cases before COVID, increased to 12.5% during the pandemic. Moreover, around half of the total suspected cases sought consultation from an ophthalmologist within a week of symptom onset in both periods. Despite fluctuations, the prevalence of hypertension, diabetes mellitus, and cataracts remained approximately 10%, 10%, and 2.7%, respectively, across both study periods. Notably, the COVID-19 period exhibited a higher association of viral and bacterial infections (Table 1).

Characteristics analysis of infectious agent-associated ocular infections

Among 1,129 cases associated with infectious agents, 950 were indicative of viral infections. Within this subset, the age groups 21-30 (23.4%) and 31-40 (19.7%) showed the highest prevalence. A similar pattern emerged in cases suspected to be viral in nature. Males exhibited a higher susceptibility to infectious agent-related eye infections (57.7% for all infectious agents, and 58.7% for viral infections). The presentation trend of unilateral cases persisted in both infectious agent-associated cases and suspected viral cases. Although both eyes were affected, a slightly higher incidence was observed in the right eye (32% versus 31%) (Table 2).

Clinical spectrum

Eye redness was a universal feature across all cases, irrespective of the causative agent, while eye-watering was noted in 84.1% of all cases and 100% of suspected viral cases. Discharge was more common in bacterial infections (100%) compared to viral infections (19.9%). Itching was observed in approximately 26.1% of cases with viral origin and 25.8% in bacterial infections. Eye pain was reported in 42.8% of all infectious agent-related cases, rising slightly to 43.9% in suspected viral cases and lowering to 37.2% in bacterial cases. Additionally, viral-associated cases displayed a higher prevalence of blurred vision (5.7%) compared to infectious agent-associated cases (5.3%) (Table 2).

Co-morbidities associated

Among the 950 suspected viral cases, 70% sought medical attention within a week. Approximately 6.9% had hypertension, 2.2% had cataracts, and 8% had diabetes mellitus. Similar patterns were observed in cases suspected of bacterial infections, with co-morbidities reported as 6.8% for hypertension, 8.0% for diabetes mellitus, and 1.6% for cataracts (Table 2).

Interrupted time deries trend analysis

The analysis of ocular infections indicated stationary processes for both viral and bacterial infections from August 2017 to August 2021, according to the Dickey-Fuller test for unit roots (Figure 2). However, the data showcased an increase in ocular infection rates during both the first and second waves of COVID-19. Notably, the second wave exhibited a higher prevalence of bacterial infections compared to viral infections, peaking in May and June 2021 (Figure 2).

Figure 1

A time series graph showing the trends of the bacterial and viral infections observed over a period

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/91b74b45-7dc9-4cb6-b072-6d31bcd81c31/image/a29bf62e-a9ea-4281-9938-85b5f602d569-uimage.png

Viral infection

The pre-COVID-19 period exhibited an ascending trend in viral ocular infections, which changed during the COVID-19 period, resulting in a 0.17% decrease in infection rates (Figure 3 - Graph A).

Figure 2

Interrupted time series graphs with the data points are plotted and the combination of trend lines and counterfactual allows visualization of the change in level from counterfactual to post-Covid trend as well as the change in slope. The timing of the interruption is indicated by a vertical line where Graph – A shows Viral Infection and Graph – B shows Bacterial Infection

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/91b74b45-7dc9-4cb6-b072-6d31bcd81c31/image/7856304a-1392-4257-b997-cc8fcc7836bc-uimage.png

Bacterial infection

Trend analysis from August 2017 to August 2021 indicated a decline of 0.17% in bacterial infections. This trend remained consistent both pre and post-COVID-19 (Figure 3, Graph B).

Discussion

The ocular surface hosts a diverse microbial community that can be beneficial, but certain pathogens in the environment can lead to extensive infections with potentially severe clinical consequences.15 Patients may experience either corneal ulcers (keratitis) or conjunctivitis, depending on whether the infection affects the cornea or the conjunctiva.15

Conjunctivitis, whether infectious or non-infectious, frequently affects the ocular surface. Bacteria such as Streptococcus pneumoniae, Haemophilus influenzae, and viruses like Adenovirus are the primary pathogens responsible for infectious conjunctivitis.4 In our study, around 20% of cases were linked to infectious agents, including bacteria or viruses. However, a significant portion of patients who were evaluated for possible ocular infections exhibited eye issues unrelated to infectious agents. The evolutionary cocktail of biological and immunological components comprising the eye's first line of defence plays a critical role in resolving ocular infections. Failure to appropriately manage infections can result in compromised visual acuity and severity, potentially leading to vision loss. The interaction between microbial virulence and the host stress response profoundly influences the morphological and functional consequences of ocular surface infections.16

In our study the prevalence of ocular infections was found to be 21.2% which were linked to any infectious agent. Additionally, male (57.7%) was more affected as compared to female. A study from Beijing, China (2011–2019) also reported the similar prevalence with the higher proportion of male (56.3%).17 However, in late 2019, COVID-19 emerged in Wuhan, China, rapidly spreading worldwide.18 Within a year, over 1.4 million global deaths were attributed to the disease.19 Both humans and animals have exhibited ocular side effects due to the SARS-CoV-2 virus. Ocular symptoms experienced by COVID-19 individuals include conjunctivitis, anterior uveitis, retinitis, erythema, and optic neuritis.20 COVID-19 patients frequently manifest ocular symptoms such as dry eyes, conjunctival hyperemia, congestion/conjunctivitis, ocular pain, irritation/itching/burning sensation, and a foreign body sensation.21 In our study, Redness was observed the most common clinical presentation during coronavirus pandemic (49.3%) compared to the pre-COVID period (47.2%). However, SARS-CoV-2-related ocular infections are less common compared to adenovirus or influenza viruses.20 Ocular abnormalities have been observed in 2% to 60% of SARS-CoV-2 cases.22, 23 In a study of 103 clinically confirmed SARS-CoV-2 patients, 21% exhibited eye involvement.20 Another study reported that 64.8% of COVID-19 patients had at least one eye symptom, with prevalence correlating with disease severity.22 Similarly, our study observed elevated cases of viral and bacterial eye infections during both the pandemic peaks with the unilaterality as the major factor. This may be attributed to mild COVID-19 exposure among the patients.

The distinctive climatic conditions, geography, and lifestyle on the Andaman Islands may contribute to the widespread occurrence of eye infections in the local population. Many participants in our study reported conjunctival hyperaemia, likely resulting from prolonged sunlight exposure. Research suggests that ocular infections are linked to heat and UV light. The past five years, starting from 2016, have marked the warmest globally on record.24 The escalating global temperature due to climate change has adverse health effects, including an increased prevalence of ocular conditions such as corneal issues, cataracts, glaucoma, and retinal problems.25, 26, 27 High temperatures are associated with a greater occurrence of bacterial, fungal, and amoebic keratitis, which can cause significant ocular discomfort and even threaten vision.28, 29, 30 An inflammatory response in the eye involving increased levels of cytokines like IL-1 and IL-6 has been linked to thermal energy exposure near the eye.31 Damage to the eye's thermal structures can be attributed to elevated corneal temperature due to environmental factors and an overall rise in body temperature associated with adapting to warmer climates.32

Raising public awareness about potential risk factors and preventive measures against vision loss and sunlight-induced damage is crucial. Additionally, given the perception of ocular infections as a neglected condition, routine eye health surveys are vital for the Andaman population. Symptoms resembling eye allergies may actually be indicative of infectious agent-related ocular issues. Therefore, proper surveillance and laboratory diagnosis are imperative to address the complications arising from ocular infections.

Our comprehensive analysis of ocular infections on the Andaman Islands highlights the complex interplay between infectious agents, environmental factors, and individual health. Ocular infections, whether caused by viruses or bacteria, pose a significant health concern. Our study revealed that a considerable portion of suspected ocular infections were not attributable to infectious agents, underscoring the need for accurate diagnosis and proper management. The emergence of COVID-19 brought additional challenges to the realm of ocular health. While ocular symptoms associated with COVID-19 were observed, they remained relatively less frequent compared to other viral infections. The shifts in infection patterns during the COVID-19 peaks emphasize the intricate relationships between infectious diseases and the larger healthcare landscape. Climate change, as evidenced by rising temperatures, has been identified as a potential contributing factor to the prevalence of ocular infections. The association between high temperatures and ocular discomfort underscores the need for heightened awareness and protective measures, particularly in regions like the Andaman Islands.

Future prospects in ocular health encompass a multifaceted approach. Public education campaigns focusing on the risks of ocular infections and the importance of timely diagnosis and treatment are essential. Regular eye health surveys could provide valuable insights into the evolving dynamics of ocular infections and their underlying causes. Additionally, collaboration between ophthalmologists, epidemiologists, and environmental experts is crucial to better understand the connections between climate change and ocular health, allowing for more targeted interventions and preventive strategies. Incorporating advanced diagnostic techniques, such as molecular and genetic analyses, could enhance our understanding of ocular infections and their origins. Moreover, ongoing research into the interactions between microbial virulence and host responses is essential for developing effective therapeutic interventions. As the world faces ongoing challenges posed by infectious diseases and climate change, our study underscores the importance of a holistic approach to ocular health. By integrating medical, environmental, and public health efforts, we can strive to minimize the impact of ocular infections and ensure a brighter future for eye health in the Andaman Islands and beyond.

Conclusion

Ocular infections among the population of the Andaman Islands involve a complicated interaction of infectious organisms, environmental variables, and ocular health. Most of the cases were suspect to have the association of infectious agents but by analyzing the data majority of cases found to have the association of non-infectious agents, underscoring the need for accurate diagnosis and treatment. COVID-19 elevated the ocular health complications. Though rare, COVID-19 caused eye symptoms which were similar to the infectious in origin. The complex link between infectious diseases and healthcare is shown by COVID-19 peak infection trends in this study. Rising climate change temperatures, pollution etc., may also be responsible to cause eye infections. Proper surveillance and diagnosis is needed in the Andaman Islands because extreme temperatures might cause ocular pain, one of the clinical manifestation among the cases of ocular infection. Regular eye exams can reveal ocular infection dynamics and causes in more detail. Ophthalmologists, epidemiologists, and environmentalists must work together to study how climate change affects ocular health and develop better treatments and prevention. Molecular and genetic analyses can further help the researchers to explain the actual cause of eye infections. Additioanlly, understanding the microbial pathogenicity and host responses is essential for effective treatment. A comprehensive ocular health strategy is needed despite viral diseases and climate change, according to the study. Integrated medical, environmental, and public health actions can minimize ocular infections and improve eye health in the Andaman Islands and beyond.

Source of Funding

None.

Conflicts of Interest

The authors declares that they have no competing interests.

Author’s Contributions

Conceptualization and study design were contributed by N.B. and N.M. Data and sample collection were performed by N.B. Data analysis, interpretation and critical evaluation were all contributed by N.B., N.M., B.S. and K.N. Manuscript writing and review were done by all the authors. All authors reviewed the manuscript.

Availability of Data and Materials

The data that support the findings of this study are not openly available due to reasons of sensitivity and are available from the corresponding author upon reasonable request.

References

1 

SM Leal KG Rodino WC Fowler PH Gilligan Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular InfectionsClin Microbiol Rev2021163e0007019

2 

LD Gray PH Gilligan WC Fowler Cumitech 13B, Laboratory diagnosis of ocular infectionsASM PressWashington, DC2011

3 

A Tarff A Behrens Ocular Emergencies: Red EyeMed Clin North Am2017101361539

4 

AA Azari NP Barney Conjunctivitis: a systematic review of diagnosis and treatmentJAMA20133101617219

5 

RP Kowalski SV Nayyar EG Romanowski RMQ Shanks A Mammen DK Dhaliwal The Prevalence of Bacteria, Fungi, Viruses, and Acanthamoeba From 3,004 Cases of Keratitis, Endophthalmitis, and ConjunctivitisEye Contact Lens20204652658

6 

K Oyong M Killerby CY Pan T Huynh NM Green DA Wadford Outbreak of Epidemic Keratoconjunctivitis Caused by Human Adenovirus Type D53 in an Eye Care Clinic - Los Angeles County, 2017MMWR Morb Mortal Wkly Rep2017674813479

7 

L Zhang N Zhao J Sha C Wang X Jin S Amer Virology and epidemiology analyses of global adenovirus-associated conjunctivitis outbreaks, 1953-2013Epidemiol Infect20161448166172

8 

WC Fowler AM Fowler Common anterior segment and red eye problems for the primary care specialist: Diagnosis and management Netter's Internal MedicineSaunders/Elsevier2008

9 

DM Varu MK Rhee EK Akpek G Amescua M Farid FJ Garcia-Ferrer American Academy of Ophthalmology Preferred Practice Pattern Cornea and External Disease Panel. Conjunctivitis Preferred Practice Pattern®Ophthalmology2018126194169

10 

S Blank DC Daskalakis Neisseria gonorrhoeae - Rising Infection Rates, Dwindling Treatment OptionsN Engl J Med201837919179597

11 

K Kreisel E Weston J Braxton E Llata E Torrone Keeping an Eye on Chlamydia and Gonorrhea Conjunctivitis in Infants in the United States, 2010-2015Sex Transm Dis20104463568

12 

L Mcanena SJ Knowles A Curry L Cassidy Prevalence of gonococcal conjunctivitis in adults and neonatesEye (Lond)201529787580

13 

HR Taylor MJ Burton D Haddad S West H Wright TrachomaLancet20143849960214252

14 

Census of India 2011 - Andaman & Nicobar - Series 36 - Part XII A - District Census Handbook, Andaman & Nicobar Islands2323https://censusindia.gov.in/nada/index.php/catalog/1434/study-descriptionLast accessed: 23 May, 2023

15 

AJ StLeger RR Caspi Visions of Eye Commensals: The Known and the Unknown About How the Microbiome Affects Eye DiseaseBioessays20184011e1800046

16 

JG Galletti CS DePaiva The ocular surface immune system through the eyes of agingOcul Surf20212013962

17 

W Hou X Sun J Feng Y Zhang Z Wang A 8-year retrospective clinical analysis of 272 patients of epidemic Keratoconjunctivitis in Beijing, ChinaBMC Ophthalmol2019191262

18 

WJ Guan ZY Ni Y Hu WH Liang CQ Ou JX He Clinical Characteristics of Coronavirus Disease 2019 in ChinaN Engl J Med202038218170820

19 

Coronavirus disease (COVID-19) Epidemiological Updates and Monthly Operational UpdatesWorld Health OrganizationGenevahttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports[Accessed: 28 May 2023]

20 

YH Lee YC Kim JP Shin Characteristics of Ocular Manifestations of Patients with Coronavirus Disease 2019 in Daegu Province, KoreaJ Korean Med Sci20203535e322

21 

S Soltani M Zandi SE Ahmadi B Zarandi Z Hosseini SA Rezayat Pooled Prevalence Estimate of Ocular Manifestations in COVID-19 Patients: A Systematic Review and Meta-AnalysisIran J Med Sci2022471214

22 

M Abrishami F Tohidinezhad R Daneshvar A Omidtabrizi M Amini A Sedaghat Ocular Manifestations of Hospitalized Patients with COVID-19 in Northeast of IranOcul Immunol Inflamm202028573944

23 

X Zhang X Chen L Chen C Deng X Zou W Liu The evidence of SARS-CoV-2 infection on ocular surfaceOcul Surf20201833602

24 

J Laporta ADSA Foundation Scholar Award: Early-life exposure to hyperthermia: Productive and physiological outcomes, costs, and opportunitiesJ Dairy Sci2021104111133747

25 

GJ Johnson The environment and the eyeEye (Lond)20041812123550

26 

RK Langley CB Mortimer C Mcculloch The experimental production of cataracts by exposure to heat and lightArch Ophthalmol19606347388

27 

L Kessel L Johnson H Arvidsson M Larsen The relationship between body and ambient temperature and corneal temperatureInvest Ophthalmol Vis Sci2010511265937

28 

A Walkden C Fullwood SZ Tan L Au M Armstrong AK Brahma Association Between Season, Temperature and Causative Organism in Microbial Keratitis in the UKCornea20183712155560

29 

A Pupić-Bakrač J Pupić-Bakrač MŠ Kolega R Beck Human ophthalmomyiasis caused by Oestrus ovis-first report from Croatia and review on cases from Mediterranean countriesParasitol Res2020119378393

30 

MR Mungroo NA Khan S Maciver R Siddiqui Opportunistic free-living amoebal pathogensPathog Glob Health202111627084

31 

MJ Tsai YL Hsu KY Wu RC Yang YJ Chen HS Yu Heat effect induces production of inflammatory cytokines through heat shock protein 90 pathway in cornea cellsCurr Eye Res201338446471

32 

AA Al-Ghadyan E Cotlier Rise in lens temperature on exposure to sunlight or high ambient temperatureBr J Ophthalmol19867064516



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

699-709


Authors Details

Nisha Beniwal, Kannan Thiruvengadam, Baljeet Saharan, Rehnuma Parvez, Vineeta Malik, Nagarajan Muruganandam*


Article History

Received : 23-03-2024

Accepted : 31-05-2024


Article Metrics


View Article As

 


Downlaod Files